Vít Procházka 🇨🇿🇪🇺🇺🇦

‼️Pleased to share our letter on machine learning in PET ⚛️. Thank @DrJFriedberg , for allowing us to submit it after the official response period! I´d love to hear your thoughts! ascopubs.org/doi/10.1200/JC…

I’ll tell you, there’s only one thing better than ICML – Sardinia right after ICML! Love it! 🇮🇹♥️

Right in time! Nice paper of 🇮🇹🇨🇿🇨🇭🇺🇸centers out! Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG) ⁦@StefanoLuminari⁩ ⁦@GregNowakowski⁩ ⁦@MarekTrnenyDr⁩ onlinelibrary.wiley.com/doi/epdf/10.10…

For our friends and our colleagues, especially those in community oncology, if you had the proverbial gun to your head, and you really had to chose between either MRD at End of Rx vs any or all of these various genetic classifiers to define 5/6/7/8 DLBCL subtypes as proposed by…

Very proud of my PhD student Daniel Filip for giving a talk at ICML and EHA conferences

Two important posters on elderly CHLs! 🇪🇸and especially 🇬🇧 shows vital role of anthracyclines! Know and Protect ❤️‍🩹at any cost. Cardio-oncology programs are crucial! @ESC_Journals @DrRaulCordoba @ABarrettHaem

A few questions on this topic pertaining to POLARGO and STARGLO: 1. As Dr Sehn so eloquently observed in her thoughtful discussion, does beating a control arm with such a conspicuously poor outcome compared to historical expectations meet the mark for a pivotal RCT to…

Do not miss the BIG DEBATE in Lugano (CNS prophylaxis in DLBCL)! And before that check the Czech 🇨🇿randomized trial 💉🧠poster #278 by Dr Mocikova, Prague 👏

Fascinating talk by DeSelm - CAR-T worked less well on tumours not irradiated. Irradiation reduces phosphethalamine which increases DAG in CAR-T, promoting cell function. #ICML2025

Den D a Čechoslováci 🇨🇿 ve francouzském 🇫🇷 odboji 6. června 1944 proběhlo vylodění v Normandii. Týdny před touto operací pracoval francouzský odboj napadal německé jednotky, sabotoval infrastrukturu...a v rámci něj i Čechoslováci. 😉👇🧵 za ♻️retweet♻️ díky 😎

The 🇨🇿37th Olomouc Hematology Days are coming to an end. The Young Scientists Awards go to Dr. Štach, Dr. Vajnerová @UHKT_Official, Dr. Látal @fnolomouc. Big congrats 👏Thank you all for coming! See you next year, May 20-22, 2026! @EHA_Hematology @CRCHUM @MayoClinic @UniofOxford

Love to chair @EHA_Hematology CRTH promoting workshop for young scientists! Great on-hand experience of @ABarrettHaem @tomaskreuz1. Thanks, @DrRaulCordoba for your mentorship and support!

Insightful presentation on Elderly Hodgkins in the UK by @ABarrettHaem at the 🇨🇿Annual Hematology Congress, big kudos! Proud to collaborate on 🇬🇧🇪🇺HoOP project 🤝! Very important field of study! @EHA_Hematology

Science and Education: this year we are launching EHA-CRTH workshop for young scientists! Great to have outstanding metor🇪🇸 @DrRaulCordoba, alumnus 🇨🇿@tomaskreuz1 and mentee 🇬🇧@ABarrettHaem at Annual Hematology Congress in Olomouc!

Dr Stephen Ansell to give the “Wiedermannova přednáška” lecture at XXXVII Olomoucké Hematologické Dny 2025 about “Breaking the limits: changing the treatment landscape for #elderly patients with #lymphoma”. Always an honor to learn from him #lymsm #geriheme #hematology

Honored to host 🇺🇸Dr Stephen Ansell in Olomouc! True legend, great scientist and educator from the best Hosp in the world @MayoClinic. Looking forward for his Wiedermann’s honorary lecture on elderly Hodgkin Lymphoma at the Czech Annual Hematology Conference. 🇨🇿

Proud to share 🇨🇿Hodgkin Study Group study on Proton 🌟beam therapy ⚛️ ➡️ 163 pts, with organs-at-risk dose limits or cardiovascular/pulmonary comorbidities. ➡️ outstanding long term efficacy, very limited “collateral damage” ➡️bit.ly/3FhmIRQ @geltamo

Leader of the Free World 🇺🇦🇪🇺🇬🇧🇨🇦🇳🇿🇦🇺🇯🇵🇰🇷

Harsh question to my fellow US colleagues: Do you anticipate Medicare cuts limiting your ability to follow hem-onc NCCN guidelines? 🤞 @AaronGoodman33 @AMarshallMD @Dr_AmerZeidan @AshAlizadeh @ASH_hematology @DrAEvens @michaelsbinkley @michaelwangmd @DrJFriedberg @GregNowakowski